FRI is pleased to announce that Drs. Karen Alexander and Courtney Nordeck (MPIs) have received an R01 award from the National Institute on Nursing Research for their project, titled “A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial.”
FRI is pleased to announce that Drs. Thomas R. Blue (MPI) and Michael S. Gordon (MPI) will continue their HEAL JCOIN 1 work as they have received a 5-year UM1 grant from the National Institute on Drug Abuse, the Justice Community Overdose Innovation Network (JCOIN) – Phase II entitled, “A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail.”
FRI is pleased to announce that Drs. Karen Alexander and Jan Gryczynski (MPIs) have received funding from the National Institute on Drug Abuse for their project “Implementing a patient navigation intervention across a health system to improve outcomes for patients with opioid use disorder.”
FRI is pleased to announce that Drs. Michael S. Gordon (MPI) and Thomas R. Blue (Co-I), along with Dr. Lauren Brinkley-Rubinstein (MPI, contact) Associate Professor in the Department of Population Health Sciences at Duke University and Dr. Curt Beckwith (MPI) from The Miriam Hospital/Rhode Island Hospital and Alpert Medical School at Brown University have received funding from the National Institute on Drug Abuse through the “Ending the HIV Epidemic: Focus on Justice Populations with SUD” R61/R33 Clinical Trial grant mechanism.
FRI proudly celebrates its 70th anniversary this year! This milestone marks seven decades of advancing science and improving lives. Founded in 1955 in Baltimore, Maryland as “Friends of Psychiatric Research,” FRI began as a small community-based organization focused on improving the quality of care of individuals with mental illness. In the ensuing years, FRI broadened its scope to address the intersecting challenges of substance use, health, and involvement in the criminal legal system. For seven decades, FRI investigators and staff have conducted groundbreaking work on some of the nation’s most vexing health and social problems. This work has helped to shape scientific understanding, clinical practice, and policy in the areas of addiction, mental health, HIV/AIDS, and criminal justice reform.
Dr. Frank Vocci was interviewed by Bloomberg News for an article about the FDA’s approval of opioids in the 1980s, when he worked as an FDA reviewer. To read the article, click here.
FRI is pleased to announce Dr. Courtney Nordeck’s promotion to the position of Research Scientist, in recognition of her scientific accomplishments and contributions to multiple FRI research studies. Dr. Nordeck first joined FRI 12 years ago. In her early years at the Institute, she worked as the Lead Site Coordinator for the NIDA CTN TAPS […]
FRI is pleased to announce that Dr. Cathy Reback, along with Drs. Chunqing Lin and Sherry Larkins (from UCLA), have received an R34 grant from the National Institute of Mental Health entitled, “Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care.”
FRI congratulates Dr. Frank Vocci, Co-Investigator of the study “A Human Abuse Potential Study of Kratom” with Dr. Christopher Verrico at Baylor College of Medicine, on the feature of their research in Bloomberg News. Click here to read the article.
FRI congratulates Dr. Mishka Terplan, who will now serve as a full Editorial Board member for Drug and Alcohol Dependence Reports, after providing outstanding service as an Editorial Board Associate.